Skip to main content

Table 1 Patient characteristics

From: Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States

 

N = 404

Gender

 Females

193 (47.8)

 Males

211 (52.2)

Age (years)

 Mean ± SD

76.6 ± 7.4

Reason for admission

 Rule out cardiac etiology

127 (31.4)

 Decompensated heart failure

80 (19.8)

 Acute coronary syndrome

68 (16.9)

 Atrial Fibrillation

43 (10.6)

 Syncope

16 (4.0)

 Bradycardia

13 (3.2)

Type of cardiovascular comorbidity

 Hypertension

303 (75.0)

 Dyslipidemia

211 (52.2)

 Coronary artery disease

200 (49.5)

 Heart failure

169 (41.8)

 Atrial fibrillation/flutter

145 (35.9)

 Diabetes mellitus

143 (35.4)

 Cardiac valve disease

61 (15.1)

 Cerebrovascular accident

52 (12.9)

 Peripheral vascular disease

47 (11.6)

 Deep venous thrombosis / pulmonary embolism

25 (6.2)

Type of non-cardiovascular comorbidity (incidence > 10%)

 Chronic kidney disease

115 (28.5)

 COPD

84 (20.8)

 GERD

79 (19.6)

 Hypothyroidism

78 (19.3)

 Cancer

77 (19.1)

 Benign prostatic hyperplasia

65 (16.1)

 Arthritis

63 (15.6)

 Anemia

47 (11.6)

  1. Data are mean ± standard deviation or n (%)
  2. COPD Chronic obstructive pulmonary disease, GERD Gastroesophageal reflux disease